IP Verse

Botulinum Toxin Assay With Improved Sensitivity

Patent No. EP3270162 (titled "Botulinum Toxin Assay With Improved Sensitivity") was filed by Biomadison on Aug 8, 2014. The application was issued on Aug 16, 2023.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERZ PHARMAMar 30, 2021HERZOG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3270162

BIOMADISON
Application Number
EP17183975A
Filing Date
Aug 8, 2014
Status
Patent Maintained As Amended
Jul 14, 2023
Publication Date
Aug 16, 2023
External Links
Slate, Register , Google Patents